NASDAQ$ALBT
Avalon GloboCare Corp · Q4 2026 earnings
Q4 2026 earnings · · Before market open · Investor relations
Briefing
Avalon GloboCare (ALBT) reported Q1 calendar 2026 operations with a net loss of $4.5M and diluted loss per share of $0.50.
For the three months ended March 31, 2026, Avalon GloboCare reported no income from its equity-method lab services investment (versus $0.4 million prior year) and operating expenses of $2.7 million. Total net loss was $4.5 million, or $0.50 per share, compared with a $2.5 million loss a year ago. Losses reflected higher marketing, professional fees, amortization, and fair-value losses on derivatives. The company remains pre-revenue on a consolidated operating basis outside legacy equity-method income.
- Net loss $4.5M vs $2.5M prior-year quarter; EPS $(0.50).
- No equity-method income in Q1 2026 vs $393K prior year.
- Operating expense base ~$2.7M including amortization and professional fees.
- Derivative fair-value losses a significant other expense item.
- Micro-cap biotech/platform; liquidity and going-concern risks in risk factors.
Headline financials
Revenue & EPS history
Avalon GloboCare · Revenue · Quarterly
$0
Forward guidance
No quantitative guidance; the company discusses strategic initiatives and financing needs without issuing EPS or revenue outlook.
Tailwinds
- Reduced net loss from continuing ops vs prior year on some expense lines.
Headwinds
- No recurring operating revenue scale.
- Derivative and financing overhang.
- Continued losses from discontinued operations.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2026
+6.9%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-6.0%
Avg return
30 days after
35%
13 / 37 earnings
Positive
+284.4%
Q1 2024
Best reaction
-13.1%
Q1 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +0.0% | -14.8% | — | |
| Q3 2025 | +0.0% | -14.4% | -44.2% | |
| Q2 2025 | +4.1% | -9.1% | +27.9% | |
| Q1 2025 | -2.1% | -3.9% | -22.0% | |
| Q4 2024 | +1.7% | -18.8% | -26.0% | |
| Q3 2024 | -8.8% | -7.9% | +41.2% | |
| Q2 2024 | +4.4% | -9.0% | -41.4% | |
| Q1 2024 | +284.4% | +116.6% | +46.9% | |
| Q4 2023 | -2.1% | -4.4% | -17.5% | |
| Q3 2023 | +4.7% | -3.2% | -25.4% | |
| Q2 2023 | -9.1% | -4.1% | -13.2% | |
| Q1 2023 | +12.6% | +0.0% | +4.0% | |
| Q4 2022 | -2.9% | -8.8% | -5.9% | |
| Q3 2022 | -1.8% | -10.6% | -8.1% | |
| Q2 2022 | -5.3% | -9.3% | -17.9% | |
| Q1 2022 | +3.5% | -5.5% | +16.0% | |
| Q4 2021 | -2.7% | +1.4% | -26.4% | |
| Q3 2021 | +0.0% | -4.8% | -15.4% | |
| Q2 2021 | -12.9% | -14.5% | -21.2% | |
| Q1 2021 | +12.7% | +14.6% | +30.6% | |
| Q4 2020 | -2.7% | +2.7% | -99.4% | |
| Q3 2020 | +6.1% | +6.1% | +7.9% | |
| Q2 2020 | +0.0% | -4.3% | -11.8% | |
| Q1 2020 | -13.1% | -21.2% | +34.3% | |
| Q4 2019 | +3.1% | -1.0% | -7.2% | |
| Q3 2019 | -8.5% | -11.1% | -22.1% | |
| Q2 2019 | -2.7% | -7.3% | -19.2% | |
| Q1 2019 | +4.3% | -13.0% | -53.3% | |
| Q4 2018 | -0.4% | +14.2% | +117.2% | |
| Q3 2018 | +0.0% | -1.1% | +0.0% | |
| Q2 2018 | -3.6% | +5.5% | +4.0% | |
| Q1 2018 | +2.1% | +26.1% | -19.1% | |
| Q4 2017 | -4.0% | — | — | |
| Q3 2017 | +5.3% | — | — | |
| Q2 2017 | +0.0% | — | — | |
| Q1 2017 | +0.0% | — | — | |
| Q4 2016 | -10.4% | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro